1-anilino-8-naphthalenesulfonate has been researched along with Demyelinating Diseases in 2 studies
1-anilino-8-naphthalenesulfonate: RN given refers to parent cpd
8-anilinonaphthalene-1-sulfonic acid : A naphthalenesulfonic acid that is naphthalene-1-sulfonic acid substituted by a phenylamino group at position 8.
Demyelinating Diseases: Diseases characterized by loss or dysfunction of myelin in the central or peripheral nervous system.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Vesterhus, M | 1 |
Raeder, H | 1 |
Aurlien, H | 1 |
Gjesdal, CG | 1 |
Bredrup, C | 1 |
Holm, PI | 1 |
Molven, A | 1 |
Bindoff, L | 1 |
Berstad, A | 1 |
Njølstad, PR | 1 |
Hirsch, HE | 1 |
2 other studies available for 1-anilino-8-naphthalenesulfonate and Demyelinating Diseases
Article | Year |
---|---|
Neurological features and enzyme therapy in patients with endocrine and exocrine pancreas dysfunction due to CEL mutations.
Topics: Demyelinating Diseases; Enzyme Therapy; Feces; Glycated Hemoglobin; Humans; Islets of Langerhans; Li | 2008 |
Pathogenesis of demyelination in multiple sclerosis: contributions of microanalysis.
Topics: Astrocytes; Body Water; Carboxypeptidase B; Carboxypeptidases; Demyelinating Diseases; DNA; Endopept | 1980 |